Selective serotonin reuptake inhibitors (SSRI's) in pregnancy and adverse fetal and infant outcomes

Principal Investigator:

Dr Shi Wu Wen, University of Ottawa

Co-Investigator:

Dr Carl Nimrod, University of Ottawa
Dr William Fraser, University of Montreal
Dr Peter Garner, University of Ottawa
Dr Mark Walker, University of Ottawa
Olufemi Olatunbosun, University of Saskatchewan

Funding Agency:

Hospital for Sick Children's Foundation

Objectives:

To determine if inutero exposure to SSRI's is associated with increased risk of adverse fetal and infant outcomes, including fetal death, birth defects, fetal growth restriction, preterm birth and severe neonatal diseases such as seizures, and infant death.